Chongqing Zhifei Biological Products Co.Ltd(300122) on February 8, the performance express of 2021 was released. During the reporting period, the company achieved an operating revenue of 30.637 billion yuan, a year-on-year increase of 101.68%; The operating profit was 11.986 billion yuan, a year-on-year increase of 207.73%; The net profit attributable to the parent company was 10.197 billion yuan, with a year-on-year increase of 208.88% and earnings per share of 6.3731 yuan.
Chongqing Zhifei Biological Products Co.Ltd(300122) said that during the reporting period, the company continued to focus on the business development objectives, increased R & D investment, pushed through the old and brought forth the new, continued to steadily improve the sales of independent products and agency products, and the company’s main business income, net profit and other important financial indicators increased significantly compared with the same period of last year.
By the end of 2021, the total assets of the company were 30.029 billion yuan, a year-on-year increase of 97.36%; The owner’s equity attributable to the parent was 17.646 billion yuan, a year-on-year increase of 113.92%; The net assets per share attributable to the parent company was 11.0285 yuan, with a year-on-year increase of 113.92%.
